Carl Byrnes

Stock Analyst at Northland Capital Markets

(0.34)
# 2578
Out of 5,347 analysts
31
Total ratings
35.29%
Success rate
-1.04%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
BLFS BioLife Solns
Maintains: Outperform
28 31
21.87 41.75% 2 Jan 8, 2025
TLSI TriSalus Life Scienc...
Initiates Coverage On: Outperform
13
5.11 144.62% 1 Oct 25, 2024
BWAY BrainsWay
Maintains: Outperform
11 13
10.21 22.43% 3 Oct 3, 2024
ONCT Oncternal Therapeuti...
Downgrades: Market Perform
2
n/a n/a 1 Sep 12, 2024
MDAI Spectral AI
Initiates Coverage On: Outperform
6
1.61 272.67% 1 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
40 25
11.62 115.15% 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
240
4 5900% 1 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 1
n/a n/a 1 Dec 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 18
n/a n/a 2 Sep 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 80
15.89 403.46% 4 Aug 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9
n/a n/a 1 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
n/a n/a 1 Oct 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
6.44 257.14% 3 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
30 24
0.85 2723.53% 4 May 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
128
n/a n/a 1 Apr 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2000
1.79 111631.84% 1 Oct 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Sep 27, 2017